Catalog No.
VVV03108
Species reactivity
Human immunodeficiency virus 1
Host species
Human
Isotype
IgG1, kappa
Clonality
Monoclonal
Target
Envelope glycoprotein gp160, Env polyprotein, Surface protein gp120, SU, Glycoprotein 120, gp120, Transmembrane protein gp41, TM, Glycoprotein 41, gp41, env, HIV1
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
G9HS63
Applications
ELISA, Neutralization
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
CH59
HIV-1 Entry and Membrane Fusion Inhibitors. PMID: 33922579
How HIV-1 entry mechanism and broadly neutralizing antibodies guide structure-based vaccine design. PMID: 28422787
The env gene variability is not directly related to the high cytopathogenicity of an HIV1 variant. PMID: 2371777
Peptide Triazole Inhibitors of HIV-1: Hijackers of Env Metastability. PMID: 35692162
Sequencing the Biology of Entry: The Retroviral env Gene. PMID: 28688086
HIV-1 replication. PMID: 12465460
HIV-1 pseudoviruses constructed in China regulatory laboratory. PMID: 31859609
Soluble Prefusion Closed DS-SOSIP.664-Env Trimers of Diverse HIV-1 Strains. PMID: 29212041
RRE-dependent HIV-1 Env RNA effects on Gag protein expression, assembly and release. PMID: 24971705
Reducing HIV-1 env gene CpG frequency increases the replication capacity of the HXB2 virus strain. PMID: 35041864
HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation. PMID: 21762802
Construction and Characterization of HIV-1 env-Pseudoviruses of the Recombinant Form CRF63_02A and Subtype A6. PMID: 35501651
Immunogenicity of HIV-1 envelope glycoprotein oligomers. PMID: 20048701
Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators. PMID: 34627310
HIV1 cytopathogenicity-genetic difference between direct cytotoxic and fusogenic effect. PMID: 1733106
Vpr Enhances HIV-1 Env Processing and Virion Infectivity in Macrophages by Modulating TET2-Dependent IFITM3 Expression. PMID: 31431548
Structure of the transmembrane domain of HIV-1 envelope glycoprotein. PMID: 27868386
Association of envelope-specific B-cell differentiation and viral selective pressure signatures in HIV-1 CRF01_AE infection. PMID: 35848590
HIV-1 Envelope FRETted Over by Antibodies. PMID: 31194935
Receptor Activation of HIV-1 Env Leads to Asymmetric Exposure of the gp41 Trimer. PMID: 27992602
[Revisiting HIV-1 assembly]. PMID: 18198110
AIDS virus envelope spike structure. PMID: 17395457
Breadth of HIV-1 Env-specific antibody-dependent cellular cytotoxicity: relevance to global HIV vaccine design. PMID: 24937308
Small Molecule HIV-1 Attachment Inhibitors: Discovery, Mode of Action and Structural Basis of Inhibition. PMID: 34066522
Phylogenetics of HIV-1 subtype G env: Greater complexity and older origins than previously reported. PMID: 26190450
Dolutegravir inhibits HIV-1 Env evolution in primary human cells. PMID: 25849829
Recent advance in the structural analysis of HIV-1 envelope protein. PMID: 25921945
Defining HIV-1 Envelope N-Glycan Microdomains through Site-Specific Heterogeneity Profiles. PMID: 30305355
Variable infectivity and conserved engagement in cell-to-cell viral transfer by HIV-1 Env from Clade B transmitted founder clones. PMID: 30415130
HIV-1 Envelope Glycoprotein at the Interface of Host Restriction and Virus Evasion. PMID: 30935048
Use of dual recombinant vaccinia virus vectors to assay viral glycoprotein-mediated fusion with transfection-resistant primary cell targets. PMID: 15114024
Genotypic characterization of CRF01_AE env genes derived from human immunodeficiency virus type 1-infected patients residing in central Thailand. PMID: 19108694
Neutralization Sensitivity of HIV-1 CRF07_BC From an Untreated Patient With a Focus on Evolution Over Time. PMID: 35372102
Functional and structural segregation of overlapping helices in HIV-1. PMID: 35511220
Reverted HIV-1 Mutants in CD4+ T-Cells Reveal Critical Residues in the Polar Region of Viral Envelope Glycoprotein. PMID: 34935422
High throughput functional analysis of HIV-1 env genes without cloning. PMID: 17416428
Genotypic tests for determining coreceptor usage of HIV-1. PMID: 21288812
Variations in Env at amino acids 328 and 330 affect HIV-1 replicative fitness and entry inhibitor sensitivity. PMID: 33862046
CpG Frequency in the 5' Third of the env Gene Determines Sensitivity of Primary HIV-1 Strains to the Zinc-Finger Antiviral Protein. PMID: 31937644
Validation of an automated system for aliquoting of HIV-1 Env-pseudotyped virus stocks. PMID: 29300769
HIV Rev Assembly on the Rev Response Element (RRE): A Structural Perspective. PMID: 26075509
Centralized HIV-1 envelope immunogens and neutralizing antibodies. PMID: 18045113
HIV1 V3 loop hypermutability is enhanced by the guanine usage bias in the part of env gene coding for it. PMID: 20109155
Altering an artificial Gagpolnef polyprotein and mode of ENV co-administration affects the immunogenicity of a clade C HIV DNA vaccine. PMID: 22509350
Syncytin-1 nonfusogenic activities modulate inflammation and contribute to preeclampsia pathogenesis. PMID: 35536515
Origins and evolutionary consequences of ancient endogenous retroviruses. PMID: 30962577
HIV Env on Lockdown. PMID: 29902434
Mechanisms for Env glycoprotein acquisition by retroviruses. PMID: 21247353
Probing Structural Variation and Dynamics in the HIV-1 Env Fusion Glycoprotein. PMID: 29268688
HIV-1 Envelope Conformation, Allostery, and Dynamics. PMID: 34067073
A new therapeutic approach for type 1 diabetes: Rationale for GNbAC1, an anti-HERV-W-Env monoclonal antibody. PMID: 29749030
The Interplay between HIV-1 Gag Binding to the Plasma Membrane and Env Incorporation. PMID: 32429351
The role of matrix in HIV-1 envelope glycoprotein incorporation. PMID: 24933691
Editorial: The HIV/SIV Envelope Protein: From Structure To Function To Host Evasion. PMID: 29708481
Structural principles controlling HIV envelope glycosylation. PMID: 28363124
Cell fusion induced senescence. PMID: 24859630
Polyadenylation of Friend murine leukemia virus env-mRNA is affected by its splicing. PMID: 24935657
HIV-1 envelope glycoprotein structure. PMID: 23602427
Glycosylation Benchmark Profile for HIV-1 Envelope Glycoprotein Production Based on Eleven Env Trimers. PMID: 28202756
HIV-1 assembly, budding, and maturation. PMID: 22762019
Cell fusions in mammals. PMID: 18351375
An efficiently cleaved HIV-1 clade C Env selectively binds to neutralizing antibodies. PMID: 25822521
Metastable HIV-1 Surface Protein Env Sensitizes Cell Membranes to Transformation and Poration by Dual-Acting Virucidal Entry Inhibitors. PMID: 31942789
Reconstitution of Fusion-Competent Human Placental Fusogen Syncytin-2. PMID: 35596004
Antibody epitope exposure and neutralization of HIV-1. PMID: 21128886
Virus and cell fusion mechanisms. PMID: 25000995
Confronting the fissions and fusions of human fertilization. PMID: 24771117
Cryo-EM Structure of Full-length HIV-1 Env Bound With the Fab of Antibody PG16. PMID: 31931014
Glycosylation profiling to evaluate glycoprotein immunogens against HIV-1. PMID: 28870097
Synthesis and assembly of chimeric human immunodeficiency virus gag pseudovirions. PMID: 8957668
HIV-1 Env trimer opens through an asymmetric intermediate in which individual protomers adopt distinct conformations. PMID: 29561264
Retroviral host range extension is coupled with Env-activating mutations resulting in receptor-independent entry. PMID: 28607078
Truncation of cytoplasmic tail of EIAV Env increases the pathogenic necrosis. PMID: 18294721
Comment to "Syncytin expression in human placental trophoblast". PMID: 35691202
ALV-J GP37 molecular analysis reveals novel virus-adapted sites and three tyrosine-based Env species. PMID: 25849207
Functions of HIV envelope glycans. PMID: 8160267
For research use only. Not for human or drug use.
